Stefan Oelrich
Global Head of Pharmaceuticals at Bayer AG and industry veteran leading transformation in drug discovery and access, with extensive experience in R&D strategy and global operations.
Best podcasts with Stefan Oelrich
Ranked by the Snipd community
11 snips
Dec 22, 2025 • 26min
Corner Office Conversation with Stefan Oelrich, Head of Pharmaceuticals Division, Bayer AG
Stefan Oelrich, Head of Pharmaceuticals at Bayer AG, discusses the evolving pharmaceutical landscape characterized by the shift of innovation from Europe to the US and China. He advocates for faster regulations to enhance patient access and shares insights on Bayer's strategy to offset revenue losses from blockbuster drugs. Oelrich highlights India's potential as a testing ground for affordability and access while emphasizing the importance of innovation over size. He also outlines Bayer's ambitions in cell and gene therapies, aiming to reach patients swiftly with new breakthrough treatments.
Dec 22, 2025 • 26min
Corner Office Conversation with Stefan Oelrich, Head of Pharmaceuticals Division, Bayer AG
Stefan Oelrich, Global Head of Pharmaceuticals at Bayer AG, shares insights on the dynamic pharmaceutical landscape. He discusses challenges, such as Europe's struggle with innovation amid rising competition from the US and China, and underscores the need for faster regulations. Oelrich highlights Bayer's focus on new drug launches to counter revenue losses and emphasizes the importance of equitable access to breakthroughs, particularly as they explore cell and gene therapies. His optimism for India's market potential showcases Bayer's strategic partnerships and a tailored approach to local needs.
